GlassScriptPhysician profile
Jacqueline Deckard
NPI 1164003661
$513.51
in general payments reported to CMS, 2019-2025
9 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $152 · 2023: $65.11 · 2024: $155 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $361.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $139.42 | 2022-2025 | Collagenase Santyl, Stravix, Grafix Pl |
| Solventum Corporation | $123.61 | 2024-2025 | Prevena, Activ.A.C. |
| Bioventus LLC | $122.66 | 2022 | |
| Kci USA, INC. | $39.50 | 2023 | Activ.A.C., Promogran Prisma |
| Organogenesis INC. | $23.80 | 2025 | Puraply Wound Matrix |
| Lifenet Health | $18.16 | 2023-2025 | Theragenesis Wound Matrix |
| Molnlycke Health Care US, LLC | $17.04 | 2023 | Exufiber Ag+, Mepilex Border Flex, Mepilex Border Post-Op Ag |
| Stryker Corporation | $15.71 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $13.61 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Deckard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.